<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="154706">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01900691</url>
  </required_header>
  <id_info>
    <org_study_id>11-012</org_study_id>
    <nct_id>NCT01900691</nct_id>
  </id_info>
  <brief_title>Removal of the Evolution® Esophageal Stent - Fully Covered</brief_title>
  <acronym>CLARITY</acronym>
  <official_title>Clinical Investigation to Evaluate Removal of the Evolution® Esophageal Stent - Fully Covered</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cook</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cook</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The CLARITY study is a clinical trial approved by US FDA to study the removal of the
      Evolution® Esophageal Stent-Fully Covered in malignant and benign indications.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Successful removal of study stent</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical success</measure>
    <time_frame>7 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dysphagia</measure>
    <time_frame>0 - 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of procedural- and/or device-related adverse events</measure>
    <time_frame>0 - 6 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of stent removal-related adverse events</measure>
    <time_frame>30 days post-removal</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device integrity during the stent removal procedure</measure>
    <time_frame>At stent removal (up to 6 months)</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Technical success</measure>
    <time_frame>at the end of the stent placement procedure</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Esophageal Fistula</condition>
  <condition>Esophageal Neoplasms</condition>
  <condition>Esophageal Perforation</condition>
  <condition>Esophageal Stenosis</condition>
  <condition>Stents</condition>
  <arm_group>
    <arm_group_label>Evolution® Esophageal Stent</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Evolution® Esophageal Stent - Fully Covered</intervention_name>
    <description>Placement of the Evolution® Esophageal Stent for benign or malignant strictures, fistulas, perforations or leaks with the intention of removal</description>
    <arm_group_label>Evolution® Esophageal Stent</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is diagnosed with benign or malignant stricture, fistula, perforation, or
             leak

          -  Physician plans to remove the stent within the duration of study follow-up

        Exclusion Criteria:

          -  Patient is &lt; 18 years of age

          -  Patient is unable or unwilling to provide written informed consent or comply with
             follow-up schedule

          -  Patient is pregnant, lactating, or planning on being pregnant within the next 6
             months

          -  Patient is simultaneously participating in another investigational drug or device
             study

          -  Patient that is contraindicated to upper GI endoscopy and/or any procedure to be
             performed in conjunction with esophageal stent placement

          -  Patient has a known hypersensitivity or contraindication to study products that, in
             the opinion of the investigator, cannot be adequately pre-medicated
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Vargo, M.D., M.P.H.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maureen Timko</last_name>
    <phone>765-463-7537</phone>
    <email>mtimko@medinst.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Harbor-University of California Los Angeles Medical Center</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90502-2004</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sofiya Reicher, MD</last_name>
      <phone>310-222-2475</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Loyola University Medical Center</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neil Gupta, MD</last_name>
      <phone>708-216-2057</phone>
      <email>jrindels@lumc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Mississippi Medical Center</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shou Tang, MD</last_name>
      <phone>601-984-4540</phone>
      <email>stang@umc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cynthia Miller, RN</last_name>
      <phone>215-955-8108</phone>
      <email>Cynthia.miller@jefferson.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Virginia Health System</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bryan Sauer, MD</last_name>
      <phone>434-924-9582</phone>
      <email>bryansauer@virginia.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Froedtert Hospital</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kulwinder Dua, MD</last_name>
      <phone>414-995-6804</phone>
      <email>kdua@mcw.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 14, 2014</lastchanged_date>
  <firstreceived_date>July 1, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Esophageal Fistula</keyword>
  <keyword>Esophageal Neoplasms</keyword>
  <keyword>Esophageal Perforation</keyword>
  <keyword>Esophageal Stenosis</keyword>
  <keyword>Stents</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Esophageal Fistula</mesh_term>
    <mesh_term>Esophageal Neoplasms</mesh_term>
    <mesh_term>Esophageal Perforation</mesh_term>
    <mesh_term>Esophageal Stenosis</mesh_term>
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
